205 related articles for article (PubMed ID: 15964851)
1. Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases.
Wang AH; Grégoire S; Zika E; Xiao L; Li CS; Li H; Wright KL; Ting JP; Yang XJ
J Biol Chem; 2005 Aug; 280(32):29117-27. PubMed ID: 15964851
[TBL] [Abstract][Full Text] [Related]
2. Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK.
McKinsey TA; Kuwahara K; Bezprozvannaya S; Olson EN
Mol Biol Cell; 2006 Jan; 17(1):438-47. PubMed ID: 16236793
[TBL] [Abstract][Full Text] [Related]
3. Sequence-specific recognition of a PxLPxI/L motif by an ankyrin repeat tumbler lock.
Xu C; Jin J; Bian C; Lam R; Tian R; Weist R; You L; Nie J; Bochkarev A; Tempel W; Tan CS; Wasney GA; Vedadi M; Gish GD; Arrowsmith CH; Pawson T; Yang XJ; Min J
Sci Signal; 2012 May; 5(226):ra39. PubMed ID: 22649097
[TBL] [Abstract][Full Text] [Related]
4. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
[TBL] [Abstract][Full Text] [Related]
5. Identification and functional characterization of ankyrin-repeat family protein ANKRA as a protein interacting with BKCa channel.
Lim HH; Park CS
Mol Biol Cell; 2005 Mar; 16(3):1013-25. PubMed ID: 15616191
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2.
Han A; He J; Wu Y; Liu JO; Chen L
J Mol Biol; 2005 Jan; 345(1):91-102. PubMed ID: 15567413
[TBL] [Abstract][Full Text] [Related]
7. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Functional Characterization of Histone Deacetylase 4 (HDAC4).
Li L; Yang XJ
Methods Mol Biol; 2016; 1436():31-45. PubMed ID: 27246207
[TBL] [Abstract][Full Text] [Related]
9. Class II histone deacetylases: structure, function, and regulation.
Bertos NR; Wang AH; Yang XJ
Biochem Cell Biol; 2001; 79(3):243-52. PubMed ID: 11467738
[TBL] [Abstract][Full Text] [Related]
10. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor.
Zhang CL; McKinsey TA; Lu JR; Olson EN
J Biol Chem; 2001 Jan; 276(1):35-9. PubMed ID: 11022042
[TBL] [Abstract][Full Text] [Related]
11. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
Grégoire S; Yang XJ
Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
[TBL] [Abstract][Full Text] [Related]
12. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor.
Lemercier C; Brocard MP; Puvion-Dutilleul F; Kao HY; Albagli O; Khochbin S
J Biol Chem; 2002 Jun; 277(24):22045-52. PubMed ID: 11929873
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
14. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity.
Lemercier C; Verdel A; Galloo B; Curtet S; Brocard MP; Khochbin S
J Biol Chem; 2000 May; 275(20):15594-9. PubMed ID: 10748098
[TBL] [Abstract][Full Text] [Related]
15. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
Grégoire S; Xiao L; Nie J; Zhang X; Xu M; Li J; Wong J; Seto E; Yang XJ
Mol Cell Biol; 2007 Feb; 27(4):1280-95. PubMed ID: 17158926
[TBL] [Abstract][Full Text] [Related]
17. Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis.
Paroni G; Mizzau M; Henderson C; Del Sal G; Schneider C; Brancolini C
Mol Biol Cell; 2004 Jun; 15(6):2804-18. PubMed ID: 15075374
[TBL] [Abstract][Full Text] [Related]
18. Associations and interactions between bare lymphocyte syndrome factors.
DeSandro AM; Nagarajan UM; Boss JM
Mol Cell Biol; 2000 Sep; 20(17):6587-99. PubMed ID: 10938133
[TBL] [Abstract][Full Text] [Related]
19. The nuclear localization domain of the MEF2 family of transcription factors shows member-specific features and mediates the nuclear import of histone deacetylase 4.
Borghi S; Molinari S; Razzini G; Parise F; Battini R; Ferrari S
J Cell Sci; 2001 Dec; 114(Pt 24):4477-83. PubMed ID: 11792813
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of an amino-terminal region of HDAC4 that possesses MEF2 binding and transcriptional repressive activity.
Chan JK; Sun L; Yang XJ; Zhu G; Wu Z
J Biol Chem; 2003 Jun; 278(26):23515-21. PubMed ID: 12709441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
